Scheithauer B W, Horvath E, Kovacs K, Laws E R, Randall R V, Ryan N
Semin Diagn Pathol. 1986 Feb;3(1):69-82.
Plurihormonal adenomas of the pituitary, ie, tumors that engage in the production of unusual combinations of hormones, represent approximately 10% to 15% of all adenomas. Such tumors comprise in excess of 50% of adenomas in the setting of acromegaly and occur with somewhat greater frequency in childhood and adolescence than in adulthood. Eight percent are associated with multiple endocrine neoplasia, type I. The most common variant of plurihormonal adenoma produces growth hormone, prolactin, and one or more glycoprotein hormones, the most common being TSH. Clinical effects most often reflect the presence of growth hormone, and to a lesser extent, prolactin cells; expression of glycoprotein hormone production is rare. The tumors are more often macroadenomas (80%) than microadenomas (20%) and demonstrate gross invasion in 50% of cases. Plurihormonal adenomas may be ultrastructurally monomorphous, bimorphous, or trimorphous; thus, one morphologic cell type may elaborate several hormones.
垂体多激素腺瘤,即产生异常激素组合的肿瘤,约占所有腺瘤的10%至15%。在肢端肥大症患者中,此类肿瘤占腺瘤的比例超过50%,在儿童和青少年中的发生率略高于成年人。8%与I型多发性内分泌腺瘤病相关。多激素腺瘤最常见的变体产生生长激素、催乳素和一种或多种糖蛋白激素,最常见的是促甲状腺激素。临床症状通常反映生长激素的存在,其次是催乳素细胞;糖蛋白激素产生的表现很少见。这些肿瘤多为大腺瘤(80%),而非微腺瘤(20%),50%的病例显示有肉眼可见的侵袭。多激素腺瘤在超微结构上可能是单形性、双形性或三形性;因此,一种形态学细胞类型可能分泌多种激素。